// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
USP has launched the newest tool in our suite of solutions to address the evolving nitrosamines c
To help strengthen the pharmaceutical supply chain and guard against potential shortages that can
When the UN General Assembly declared March 8 a day to support women's rights and participation i